These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 19763357)

  • 21. Prophylaxis for severe haemophilia: clinical challenges in the absence as well as in the presence of inhibitors.
    Fischer K; Valentino L; Ljung R; Blanchette V
    Haemophilia; 2008 Jul; 14 Suppl 3():196-201. PubMed ID: 18510542
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The role of rehabilitation and sports in haemophilia patients with inhibitors.
    Heijnen L
    Haemophilia; 2008 Nov; 14 Suppl 6():45-51. PubMed ID: 19134033
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rofecoxib as adjunctive therapy for haemophilic arthropathy.
    Rattray B; Nugent DJ; Young G
    Haemophilia; 2005 May; 11(3):240-4. PubMed ID: 15876269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Recurrent intra-articular bleeding episodes in haemophiliacs. Treatment outcomes in the patients at the university hospital motol in 1985-2005].
    Teyssler P; Trč T; Kološtová K; Bobek V
    Acta Chir Orthop Traumatol Cech; 2013; 80(6):396-9. PubMed ID: 24750967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical evaluation after 1 year of 153-samarium hydroxyapatite synovectomy in patients with haemophilic arthropathy.
    Calegaro JU; Machado J; DE Paula JC; DE Almeida JS; Casulari LA
    Haemophilia; 2009 Jan; 15(1):240-6. PubMed ID: 18976248
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A 6-year follow-up of dosing, coagulation factor levels and bleedings in relation to joint status in the prophylactic treatment of haemophilia.
    Ahnström J; Berntorp E; Lindvall K; Björkman S
    Haemophilia; 2004 Nov; 10(6):689-97. PubMed ID: 15569163
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synoviorthesis with colloidal 32P chromic phosphate for hemophilic arthropathy: clinical follow-up.
    Rivard GE; Girard M; Lamarre C; Jutras M; Danais S; Guay JP; Bélanger RD
    Arch Phys Med Rehabil; 1985 Nov; 66(11):753-6. PubMed ID: 4062528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The use of 185 MBq and 740 MBq of 153-samarium hydroxyapatite for knee synovectomy in haemophilia.
    Calegaro JU; Machado J; Furtado RG; de Almeida JS; de Vasconcelos AV; de Barboza MF; de Paula AP
    Haemophilia; 2014 May; 20(3):421-5. PubMed ID: 24330418
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Radioactive synovectomy with Yttrium⁹⁰ citrate in haemophilic synovitis: Brazilian experience.
    Thomas S; Gabriel MB; Assi PE; Barboza M; Perri ML; Land MG; Da Costa ES;
    Haemophilia; 2011 Jan; 17(1):e211-6. PubMed ID: 20731723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The co effect of prophylaxis and radiosynovectomy on bleeding episodes in haemophilic synovitis.
    Brecelj J; Bole V; Benedik-Dolnicar M; Grmek M
    Haemophilia; 2008 May; 14(3):513-7. PubMed ID: 18248407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Intensive factor replacement for management of chronic synovitis in hemophilic children.
    Miser AW; Miser JS; Newton WA
    Am J Pediatr Hematol Oncol; 1986; 8(1):66-9. PubMed ID: 3087226
    [No Abstract]   [Full Text] [Related]  

  • 32. Post-synoviorthesis rehabilitation in haemophilia.
    Querol F; Rodriguez-Merchan EC; Aznar JA; Lopez-Cabarcos C; Villar A
    Haemophilia; 2001 Jul; 7 Suppl 2():54-8. PubMed ID: 11564147
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radioisotope synovectomy with rhenium186 in haemophilic synovitis for elbows, ankles and shoulders.
    Kavakli K; Aydogdu S; Taner M; Duman Y; Balkan C; Karapinar DY; Saydam G; Capaci K; Oktay A
    Haemophilia; 2008 May; 14(3):518-23. PubMed ID: 18371165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Radiosynoviorthesis for treatment of hemophilic hemarthrosis--Slovenian experience.
    Grmek M; Milcinski M; Fettich J; Benedik-Dolnicar M; Brecelj J
    Cancer Biother Radiopharm; 2005 Jun; 20(3):338-43. PubMed ID: 15989481
    [TBL] [Abstract][Full Text] [Related]  

  • 35. On the safety of synoviorthesis in haemophilia.
    Fernandez-Palazzi F; Caviglia H
    Haemophilia; 2001 Jul; 7 Suppl 2():50-3. PubMed ID: 11564146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimizing factor prophylaxis for the haemophilia population: where do we stand?
    Blanchette VS; Manco-Johnson M; Santagostino E; Ljung R
    Haemophilia; 2004 Oct; 10 Suppl 4():97-104. PubMed ID: 15479380
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The target joint.
    Mulder K; Llinás A
    Haemophilia; 2004 Oct; 10 Suppl 4():152-6. PubMed ID: 15479389
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synoviorthesis in haemophilic synovitis: which is the best radioactive material to use?
    Rodriguez-Merchan EC
    Haemophilia; 2005 Mar; 11(2):191. PubMed ID: 15810926
    [No Abstract]   [Full Text] [Related]  

  • 39. Identifying and overcoming barriers to prophylaxis in the management of haemophilia.
    Petrini P
    Haemophilia; 2007 Sep; 13 Suppl 2():16-22. PubMed ID: 17685919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chemical synoviorthesis with osmic acid in haemophilia.
    Ayral X
    Haemophilia; 2001 Jul; 7 Suppl 2():20-5. PubMed ID: 11564140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.